The Department of Defense (DoD) Amyotrophic Lateral Sclerosis Research Program (ALSRP) is offering the Therapeutic Development Award to improve ALS treatments. This grant supports the preclinical development of novel and existing therapeutic agents for Amyotrophic Lateral Sclerosis. Investigators should undertake empirical, product-driven preclinical studies focused directly on advancing therapeutics. The core intent is to generate agents and data leading to ALS therapeutic advancements. This award is strictly for ALS research; studies primarily focused on basic science not directly informing therapeutic development are excluded. Clinical trials are also not permitted, ensuring a clear focus on preclinical product development.
Opportunity ID: 47591
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-ALSRP-TDA |
| Funding Opportunity Title: | DoD Amyotrophic Lateral Sclerosis Research Program Therapeutic Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 27, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 15, 2009 |
| Current Closing Date for Applications: | Oct 15, 2009 |
| Archive Date: | Nov 14, 2009 |
| Estimated Total Program Funding: | $5,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | As the vision of the FY09 ALSRP is to improve treatments for ALS, the Therapeutic Development Award is being offered to support preclinical development of therapeutics for amyotrophic lateral sclerosis (ALS). Investigators are encouraged to undertake preclinical studies of novel and existing agents. The Therapeutic Development Award is restricted to research in ALS. The proposed studies are expected to be empirical in nature and product-driven, but may have a hypothesis-driven approach, provided the focus is on therapeutics. It is anticipated that the agents and/or data generated from these awards will lead to the advancement of therapeutics for ALS. Studies focused on basic science research that will not directly inform therapeutic development do not meet the intent of the award mechanism. Additionally, clinical trials will not be allowed. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 47591 Full Announcement-1 -> biosketch.pdf
Folder 47591 Full Announcement-1 -> fy09 alsrp tda pa_post-saab.pdf
Folder 47591 Full Announcement-1 -> budget form reader.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00012300 | May 27, 2009 | Oct 15, 2009 | View |
Package 1
Mandatory forms
47591 RR_SF424-1.1.pdf
47591 RR_PerformanceSite-1.1.pdf
47591 RR_KeyPersonExpanded-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
